Loading...
StocksRunner logo
 
 
Amedisys Inc
91.87
-0.78%
 
AMED Amedisys Inc
Last Price
Change
91.87
 
-0.78%
 
 
 

 
Sentiment
 
 

80.19

72.64

96.06

109.71

 
 
1m
3m
6m
1y
 

Summary

  Login to display Amedisys Inc (AMED) recommendation from the last 90 days from financial news and social media.
 

Strengths

Rewards

 Earnings are forecast to grow

Rewards

 Trading below its fair value

 

Risk Analysis

Risk Analysis

 Downgraded on weak valued

 
 

Risk Level

 
StocksRunner
 

Amedisys Inc (AMED) has Moderate Risk Level

Click here to check what is your level of risk

 

Analysts Opinion

Click on the category for more information
 
 

Earnings

×
 

Earnings

3.33
 

StocksRunner

 Above analyst estimates

 
 

Rating

×
 

Rating

1.00
 

StocksRunner

 Downgraded on weak valued

 

Momentum

×
 

Momentum

3.75
 

StocksRunner

 Has been gaining momentum

 

Activity

×
 

Activity

4.00
 
 

Future

×
 

Future

4.20
 

StocksRunner

 Earnings are forecast to grow

StocksRunner

 Trading below its fair value

 
 

Analysts Opinion

Analysts opinion is negative but has improved from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
76%
0%
75%
80%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is extremely ish and have positive views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
76%
19%
Positive
Negative
16 out of 21
events present
4 out of 21
events present
 

 
Events Calendar
Click for more information
 
May
S
M
T
W
T
F
S
June
S
M
T
W
T
F
S
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Downgrade
This Week
92.51
+0.15%
 
Partnership
This Week
91.31
+14.90%
 
Partnership
3 Weeks Ago
75.98
+2.00%
 
Strong Earnings
2 Month Ago
80.47
+2.34%
 
Top Headlines

amedisys: even without a bidding war the company appears undervalued.

Fri Jun 9, 2023

Potential

: amedisys downgraded to hold from buy at truist. this is a real-time headline. these are breaking news delivered the minute it happens delivered ticker-tape style. visit www.marketwatch.com or the e page for more information about this breaking news.

Wed Jun 7, 2023

Rating

truist securities downgrades amedisys to hold with a price target of $97.00.

Wed Jun 7, 2023

Rating

optum bid for amedisys a surprise though likely to get antitrust approval - analysts.

Mon Jun 5, 2023

Activity

option care health up 6% on amedisys disclosure of unsolicited proposal from optum. (rttnews) - shares of option care health inc. (opch) are rising more than 6% monday morning at $30.68 after it affirmed that its proposed merger with amedisys is

Mon Jun 5, 2023

Activity
Momentum
Potential

amedisys climbs 14% after announcing unsolicited acquisition proposal from optum. (rttnews) - amedisys inc. (amed) shares are gaining more than 14 percent on monday morning trade after the company announced the receipt of an unsolicited acquisit

Mon Jun 5, 2023

Activity
Momentum

amedisys breaks above 200-day moving average - ish for amed. in trading on monday shares of amedisys inc. (symbol: amed) crossed above their 200 day moving average of $90.52 changing hands as high as $91.75 per share. amedisys inc. shares a

Mon Jun 5, 2023

Momentum

amedisys stock surges on receipt of unsolicited $100/share proposal from optum.

Mon Jun 5, 2023

Momentum

amedisys gets over $3 billion unsolicited offer from unitedhealths optum. amedisys inc said on monday it had received an unsolicited proposal from unitedhealth groups health services company optum to acquire all of its outstanding shares in an a

Mon Jun 5, 2023

Activity

amedisys announces receipt of unsolicited proposal from optum. amedisys board determines optum proposal could reasonably be expectedto result in a superior proposal amedisys engaging in discussions with optum baton rouge la. june 05 2023 (globe new

Mon Jun 5, 2023

Potential

amedisys and option care health: high-probability merger arb.

Tue May 16, 2023

Activity

amedisys (amed) q1 earnings beat estimates margins dip. amedisys inc. amed reported adjusted earnings per share (eps) of $1.00 for the first quarter of 2023 down 18.7% from the year-ago figure. the bottom line surpassed the zacks conse

Thu May 4, 2023

Earnings

healthcare giants join hands: option care health acquires amedisys in a $3.6 billion stock swap. ) and) have agreed to

Thu May 4, 2023

Activity

amedisys non-gaap eps of $1.00 beats by $0.12 revenue of $556.39m misses by $2.59m.

Wed May 3, 2023

Earnings

option care to buy homecare service provider amedisys in $3.6 bln deal. homecare services provider option care health inc said on wednesday it is acquiring amedisys inc in an all-stock deal valued at $3.6 billion including debt.

Wed May 3, 2023

Activity

amedisys q1 profit decreases but beats estimates. (rttnews) - amedisys (amed) announced a profit for first quarter that decreased from the same period last year but beat the street estimates.

Wed May 3, 2023

Earnings

amedisys (amed) new buyouts aid growth cms ruling unfavorable. amedisys amed is currently exploring new opportunities in home health and hospice segments. the company&rsquo.s favorable demographic trend and strategic acquisitions under

Fri Apr 14, 2023

Potential
Potential

 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our daily AMED alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
StocksRunner

StocksRunner

Get the pulse of the market

 
StocksRunner

AMED Amedisys Inc

Last Price
91.87
Change
-0.78%
 

Summary

  Login to display Amedisys Inc (AMED) recommendation from the last 90 days from financial news and social media.

 
 
80.19
72.64
96.06
109.71
 
 
1m
3m
6m
1y
 
Sentiment

Strengths

Rewards

 Earnings are forecast to grow

Rewards

 Trading below its fair value

Risk Analysis

Risk Analysis

 Downgraded on weak valued

 
 
 
 
Street Consensus
 
Buy
Opinion
Trend
Score
Potential
Score
 
0%
75%
80%
On Track
On Track
On Track
 
76%
19%
Positive
Negative
16 out of 21
events present
4 out of 21
events present
 

Street Opinion

Street view is extremely ish and have positive views on the near-term outlook

 
 
Analysts Opinion
Hover the category for more information
 
 

Earnings

×
 

Earnings

3.33
 

StocksRunner

 Above analyst estimates

 
 

Rating

×
 

Rating

1.00
 

StocksRunner

 Downgraded on weak valued

 

Momentum

×
 

Momentum

3.75
 

StocksRunner

 Has been gaining momentum

 

Activity

×
 

Activity

4.00
 
 

Future

×
 

Future

4.20
 

StocksRunner

 Earnings are forecast to grow

StocksRunner

 Trading below its fair value

 
 

Analysts Opinion

Analysts opinion is negative but has improved from the past 3 months

 
 
 
 
 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 
Risk Level
 
StocksRunner
 

Amedisys Inc (AMED) has Moderate Risk Level.  Click here to check what is your level of risk

 
 
 

Events Calendar

Hover for information

 
May
 
S
M
T
W
T
F
S
 
June
 
S
M
T
W
T
F
S
 
 
 
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Downgrade
This Week
92.51
+0.15%
 
Partnership
This Week
91.31
+14.90%
 
Partnership
3 Weeks Ago
75.98
+2.00%
 
Strong Earnings
2 Month Ago
80.47
+2.34%
 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our daily AMED Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
 
 

Top Headlines